Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
This is the single most important section for anyone weighing the risks of BPC-157, and the honest answer is uncomfortable: there are zero completed Phase III human clinical trials for BPC-157, and the peptide has never received marketing approval from any major regulator
40mcg (as L-selenomethionine) Proprietary Blend
Using sterile equipment, disinfecting vial stoppers with alcohol before each puncture, minimizing unnecessary vial access, and refrigerating the peptide promptly after use all help support good laboratory handling practices
Whether these are equivalent in biological effect is not proven through comparative human studies
US$ 20.97
US$ 27.87
US$ 23.34
US$ 25.78
US$ 25.99
